Apheris vs Ochre Bio

<p>Apheris is a drug discovery software platform designed to advance pharmaceutical research by providing secure, local AI-driven model deployment and benchmarking. It empowers drug discovery teams to run and customize AI models in their own environment, ensuring proprietary data remains in-house. The platform supports federated data networks, enabling multiple organizations to collaboratively train and improve drug discovery models without sharing sensitive information.</p> <p>With Apheris, you can join or build federated networks spanning leading biopharma companies, fine-tune models on your own data, and integrate results via GUI or API for streamlined discovery workflows. It offers benchmarking capabilities on internal datasets, helps design more informative experimental batches, and facilitates collaboration across research teams. This powerful combination enhances your ability to develop better medicines faster while maintaining data security and control.</p>

<p>Ochre Bio is a cutting-edge platform that combines AI with large-scale human liver data to accelerate drug discovery specifically for chronic liver diseases. It enables you to explore causal disease mechanisms, validate targets in human tissue, and develop RNA therapies in-house, significantly reducing R&amp;D timelines. The platform targets the pharmaceutical industry and research organizations aiming to find effective treatments beyond liver transplants.</p> <p>With investments in proprietary datasets and integrated gene atlases, Ochre Bio supports discovery, validation, and clinical development pipelines. You benefit from access to mechanistic insights, RNA therapeutic development, and partnerships with leading companies like GSK. This platform aims to revolutionize liver disease treatment by making drug development faster and more precise.</p>